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1. Introduction 
The acetylcholine r ceptor (AChR) is not uniformly 
distributed on the surface of the striated muscle fiber 
or of the electroplaque and its density under the nerve 
terminals may exceed by a factor of 100 or even 1000 
that present in extrasynaptic areas [1 ]. Physiological 
[2,3], pharmacological [4] and biochemical [5,6] 
differences have been reported between these two 
classes of receptor but the structural basis of these 
differences yet remains to be understood. For instance, 
do separate genes code for the extra and subsynaptic 
receptors? Or, alternatively, would the different forms 
of the AChR result from a covalent modification of 
a single protein species as commonly found with 
regulatory [7] or membrane bound [8] proteins? 
To approach this problem, we have used the electric 
organ of Electrophorus electricus for which autoradio- 
graphic data indicate that the AChR is present in 
both subsynaptic and extrasynaptic areas in almost 
equal amounts [9]. In this communication, we present 
evidence that in crude detergent extracts of membrane 
fragments from E. electricus electric tissue, AChR is 
present under two forms with different isoelectric 
points. Moreover acatalytic interconversion f each 
form into the other has been achieved in vitro sug- 
gesting that a chemical modification may be respon- 
sible for the observed ifference. 
The implications of these results are discussed in 
terms of a theory of selective stabilization of develop- 
ing synapses [ 10,21 ]. 
2. Materials and methods 
2.1. Extraction o f  the cholinergic receptor 
40 g of frozen or fresh tissue of electric organ 
were homogenized into 80 ml of PNM (10 -4 M PMFS, 
a protease inhibitor, 0.02% NaN3, 0.014 M 2-mercapto- 
ethanol in H20, pH 6.2) for 2 min at 0°C using a Virtis 
blender at medium speed. This homogenate was 
centrifuged for 30 min, 20 000 g at 4°C; the pellet was 
resuspended in 20 ml PNM, and a 20% solution of 
Triton X-100 was added to obtain a final Triton X-100 
concentration of 5%. The extraction was carried out 
under gentle stirring at room temperature for 60 min. 
The suspension was then centrifuged for 60 min, 4°C 
at 100 000g and the supernatant ($2) collected and 
kept at 4°C. 
2.2. Isoelectric focusing 
The isoelectric focusing was carried out at 4°C for 
12 h in a 80 ml electrofocusing glass column [11], 
along a 52 ml sucrose gradient (44-16%) containing 
1% pH 4 -6  Ampholyte, 0.1% Triton, 0.4 M urea in 
PNM. 
3. Results 
Fig. 1 shows the results of an experiment of iso- 
electric focusing performed on a crude Triton X-100 
extract of membrane fragments prepared from electric 
organ of E. electricus. After the run, AChR was 
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Fig.1. Isoelectric focusing profile of S 2 fraction. 118 pM of 
a[ 3 H] toxin binding sites were applied. Electrofocusing was 
carried out at constant power for 12 h. 340 pt fractions were 
collected. The pH value of each fraction was determined at 
4°C. Each fraction was then neutralized with 2 M Tris buffer 
pH 7.0. AChR was assayed according to Olsen et al. [12]. 
The specific activity of the a[SH]toxin batch used was 
30 Ci/mmol and 61% of the a-toxin molecules were pharma- 
cologically active. The yield in toxin sites recovered was 56%. 
assayed in the collected 340 ~tl fractions with a[3H] 
toxin (30 Ci/mmol) from N. nigricotlis [12]. The 
profile of a [3 H] toxin binding sites consists of two 
peaks: one focusing at pH 4.57, the other at pH 4.85. 
It could be shown that the pH values at which 
AChR focuses did not depend on the place of applica- 
tion of the sample in the column and that they could 
vary from run to run by up to 0.12 pH units. In any 
event, two peaks of AChR were always observed and 
separated by at least 0.22 pH units. In order to chal- 
lenge the possibility that the two forms of AChR may 
result from a reversible quilibrium established within 
the column, the fractions composing each toxin 
binding peak were pooled, dialyzed against 0.1% 
Triton X-100 in PNM buffer concentrated on DEAE 
cellulose [13] and resubmitted to isoelectric focusing. 
Fig.2 shows that each toxin binding peak refocuses 
as a single species indicating that the two peaks 
observed in fig.1 represent two distinct and stable 
forms of AChR. Although each form keeps its relative 
acidity with respect o the other, they do not refocus 
at exactly the same isoelectric pH as the fractions 
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Fig.2. Isoelectric focusing profiles of AChR forms. Acidic 
form of AChR (o - o) 13 pmol of a[3H]toxin binding sites. 
Alkaline form of AChR (~ - a) 30 pmol of a [ 3 HI toxin 
binding sites analysed under conditions as described fig. 1. 
from which they originate. The reasons for this varia- 
bility are not known. 
Brockes and Hall [5] have reported ifferences 
in the binding properties of two AChR forms isolated 
from denervated rat diaphragm. We therefore mea- 
sured, at 20°C, the rate constant of oz[3H] toxin 
binding to each AChR form from Electrophorus [14] 
and found it to be the same in both cases: (k = 5 X 107 
M -t rain-t). The inhibition by d-tubocurarine of the 
initial rate ofa[3H]toxin binding to each AChR form 
gave an identical protection constant of 2 × 10 -7 M. 
This latter finding is in complete agreement with the 
work of Alper et al. [15]. 
The two distinct forms of AChR may either reflect 
differences in primary structure or result from a 
covalent modification of a single molecular species. 
To test this second alternative attempts were made to 
obtain an interconversion i  vitro between the two 
forms. First the possibility of an heterogeneity of
AChR forms due to the reduction of a disulfide 
bridge in the receptor by 2-mercaptoethanol was 
eliminated since the two forms of AChR could still 
be observed in the absence of reducing agent. An 
aliquot of the crude extract $2 was then incubated 
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Fig.3. lsoelectric focusing profile of S~ fraction after 0.1 M 
NaF treatment a 37°C for 30 rain and dialysis at 4°C against 
large volumes of PNM containing 0.1% Triton X-100. 
168 pmol of a[3Hltoxin binding sites were applied. The 
yield in toxin binding sites after incubation at 37°C and 
dialysis was 76% and the recovery in AChR after isoelectric 
focusing 54%. 
for 30 rain at 37°C in the presence of 0.1 M NaF in 
PNM. The extract was dialysed for 24 h against O. 1% 
Triton X-100 in PNM and submitted to isoelectric 
focusing; fig.3 shows the resulting profile of toxin 
binding activity. When the same experiment was 
carried out in the presence of 0.1 M NaC1 instead of 
NaF, then, an entirely different profile was obtained 
(fig.4). 
Clearly, after treatment at 37°C only one of the 
two forms of the AChR remains: the acidic one with 
NaF, the more alkaline one with NaC1. Treatment at 
37°C for 30 rain without any salt did not modify the 
profile shown in fig. I. 
Since a significant inactivation of AChR takes 
place during the heat treatment and the electro- 
focusing, two alternative interpretations may account 
for the observed results. Either one of the two forms 
is selectively inactivated or an interconversion between 
the two forms takes place. First of all, it could be 
shown that the electrofocusing in itself did not cause 
a selective inactivation of one of the two forms. But 
this may have taken place during the heat treatment. 
The following experiment rules out this possibility. 
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Fig.4. Isoelectric focusing profile of S~ fraction after 0.l M 
NaC1 treatment a 37°C for 30 min and dialysis at 4°C against 
large volumes of PNM containing 0.l% Triton X-100. 
198 pmol of a[3H]toxin binding sites were applied. The yield 
in toxin binding sites after incubation at 37°C and dialysis 
was 76% and the recovery in AChR after the isoelectric 
focusing 49%. 
The crude extract, $2, was first incubated in the 
presence of 0.1 M NaF under conditions which favor 
the acidic form. Then, the extract was dialysed and 
heated again at 37°C but in the presence of 0.1 M 
NaC1. The profile obtained after this second treatment 
is, again, identical to that shown in fig.4. The alkaline 
peak which disappeared after the first treatment in 
NaF, reappeared after the second exposure to NaCI. 
These results are taken as strong indication that the 
treatment of a crude extract of AChR at 37°C in the 
presence of NaC1 or NaF leads to an interconversion 
between acidic and alkaline forms rather than to a 
selective inactivation of anyone of these forms. It 
should be noticed however that in treating the crude 
membrane xtract with NaF, the conversion of the 
alkaline peak into the acidic one was not always com- 
plete and a peak was often observed around pH 4.85. 
This was not the case upon treatment of the crude 
membrane xtract with NaC1 which resulted always 
in a complete conversion into the AChR alkaline form. 
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4. Discussion 
In rat diaphragm uscle before and after denerva- 
tion, Brockes & Hall [5] have found two forms of 
a[12Sl]bungarotoxin-AChR complexes; In crude 
Triton X-100 extracts of membrane fragments from 
E. electricus electric organ, the cholinergic receptor 
protein is also present under at least two discrete 
forms with different isoelectric points. Since the 
difference in isoelectric point between the purified 
AChR (pH 4.7) from E. electricus [16] and its toxin 
complex (pH 5.15) [17] is about 0.45 pH units, the 
isoelectric properties of the two AChR forms from 
Electrophorus are very similar if not identical to those 
of the subsynaptic and extrasynaptic receptors from 
rat diaphragm. By high resolution autoradiography of 
the a [3 H] toxin-labelled electroplaque from E. electricus, 
Bourgeois et al. [9] have shown that almost equal 
amounts of subsynaptic andextrasynaptic AChR are 
present in this cell. Interestingly, this proportion is
close to that found between the two forms with 
different isoelectric points observed after detergent 
dissolution. It is therefore quite plausible that these 
two forms correspond also to extrasynaptic and sub- 
synaptic AChR. 
Whatever the origin of these two forms is, it appears 
clear that an in vitro treatment in the presence of 
salts modifies their isoelectric point. Despite the fact 
that these two stable forms of AChR are not yet 
identified chemically but distinguished only on the 
basis of their isoelectric behavior, the most likely 
interpretation f the data is that an interconversion 
between the two forms takes place in vitro. One 
possible candidate for the modification is a phos- 
phorylation-dephosphorylation reaction catalysed 
by protein kinases and phosphoprotein phosphatases 
present in the crude extract. The known inhibition 
of phosphoprotein phosphatases byNaF [18] would 
explain the differential effect of NaC1 and NaF. In 
the presence of NaF and provided that the cofactors 
needed by the protein kinase are present in the crude 
membrane extract, AChR would be phosphorylated 
and therefore should focus at a more acid pH where- 
as in the presence of NaC1 the phosphorylated AChR 
should be dephosphorylated by the phosphoprotein 
phosphatase and focus at a more basic pH. The repro- 
ductibility of the conversion of the acidic AChR into 
the alkaline species in contradistinction to the con- 
version observed in the presence of NaF could be 
explained by the stringent requirement by the protein 
kinase of cofactors that may not be present or active 
in each of our preparations. 
The functional significance of these two forms is 
still hypothetical. Among others, two interpretations 
appear plausible: (1) Following Greengard and 
co-workers [8], the two forms might be involved in 
the regulation of the permeability of the postsynaptic 
membrane by the neurotransmitter. (2) Alternatively, 
the covalent modification may be at the origin of 
striking differences instability noticed between the 
subsynaptic and extrasynaptic receptor [19,20]. This 
hypothesis has been recently applied to the develop- 
ment of the neuromuscular junction [10,21] and may, 
in particular, account for the selective accumulation 
of receptor under the nerve terminal or 'localisation' 
process. In the developing myotubes, the AChR 
would be present in its 'unmodified' form, labile and 
mobile. Under the developing nerve terminal, the 
postulated covalent modifications would immobilize 
the protein and render it resistant to degradation. If 
one further assumes [21] that the synthesis of the 
labile form of the AChR stops in the postsynaptic cell 
when the electrical activity of the myotube starts, 
then, the localisation process could be viewed as the 
management of a finite stock of receptor protein via 
lateral diffusion, covalent modification and selective 
degradation. As a consequence, the density of the 
receptor would rapidly increase under the nerve 
terminal and decrease in extrasynaptic areas. 
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